Skip to content
Screener
Q3 '26Q2 '26Q1 '26Q4 '25Q3 '25
$12.88M+11.3%$11.41M+1.7%$8.9M-2.9%$13.21M+59.8%$11.57M+57.4%
$1.78M-6.5%$1.51M-16.3%$1.23M-17.7%$1.76M+44.9%$1.91M+89.8%
$11.1M+14.9%$9.9M+5.2%$7.67M0.0%$11.44M+62.4%$9.66M+52.2%
86.2%+2.6pp86.8%+2.9pp86.2%+2.5pp86.7%+1.4pp83.5%-2.8pp
$3.19M-38.4%$3.14M-20.0%$3.22M+6.5%$2.57M-13.1%$5.18M+22.7%
$10.73M+56.9%$11.42M+59.4%$7.41M+10.1%$7.97M+13.7%$6.84M+11.4%
$4.88M-26.7%$5.16M-8.8%$5.45M+3.9%$4.17M-10.4%$6.66M+40.9%
-$7.71M+14.5%-$9.81M-33.8%-$8.41M-14.8%-$3.27M+56.8%-$9.01M-3.1%
-59.9%+18.1pp-86%-20.6pp-94.5%-14.6pp-24.8%+67.0pp-77.9%+41.0pp
$1.56M+6.8%$1.49M+4.7%$1.44M+18.8%$1.45M+36.0%$1.46M+27.8%
-$53K+43.6%$90K+325%-$76K+69.7%-$71K+30.4%-$94K-623%
-$8.85M+18.1%-$9.18M-10.8%$1.54M+115%-$9.75M+3.5%-$10.81M-350%
$4K-20.0%$4K+233%$4K-20.0%$0—$5K+267%
-$8.85M+18.1%-$9.19M-10.8%$1.54M+115%-$9.75M+3.5%-$10.81M-351%
-68.8%+24.7pp-80.5%-6.6pp17.3%+130pp-73.9%+48.5pp-93.5%-60.8pp
-$0.15+84.4%-$0.16+40.7%$0.03+108%-$0.12+70.0%-$0.96-700%
-$7.58M+14.4%-$9.68M-35.0%-$8.28M-15.6%-$3.15M+57.4%-$8.85M-3.4%
-58.9%+17.7pp-84.8%-20.9pp-93%-14.9pp-23.8%+65.6pp-76.5%+39.9pp
-$7.71M+14.5%-$9.81M-33.8%-$8.41M-14.8%-$3.27M+56.8%-$9.01M-3.1%

FAQ

What is TriSalus Life Sciences, Inc.'s revenue?
TriSalus Life Sciences, Inc. (TLSI) generated $46.4M in revenue over the trailing twelve months, up 15.4% year over year.
Is TriSalus Life Sciences, Inc. profitable?
TriSalus Life Sciences, Inc. is not currently profitable: it reported a net loss of $26.3M over the trailing twelve months, a -56.6% net margin.
What are TriSalus Life Sciences, Inc.'s profit margins?
Gross margin is 86.5% and operating margin is -63.0%, with a -56.6% net margin.
What is TriSalus Life Sciences, Inc.'s earnings per share?
TriSalus Life Sciences, Inc.'s diluted EPS over the trailing twelve months is $-0.40.
Where does TriSalus Life Sciences, Inc.'s income statement data come from?
Every line is extracted from TriSalus Life Sciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.